Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant ...

Good day, and thank you for standing by. Welcome to AST SpaceMobile's First Quarter 2026 Business Update. Please be advised that today's call is being recorded. I will now turn the conference over to ...

Hyperscale Data, Inc. , an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the ...

Argenx's 28% Surge & Promising Product Propel Investor Confidence AbCellera Biologics (NASDAQ:ABCL) said its first quarter of ...

ABCL635 demonstrated a favorable tolerability profile, with no observed liver toxicity, and achieved potent and sustained ...

SES S.A. announces financial results for the three months ended 31 March 2026. Q1 2026 Performance (€ million) Q1 2026 as reported (1) Q1 2025 as ...

Traeger, Inc. ("Traeger" or the "Company") (NYSE: COOK), creator and category leader of the wood pellet grill, today ...

DocGo Inc. ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the first quarter ...

Detailed price information for Power Solutions International (PSIX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.

Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria ...